Epigral Financial Results
- Market cap
- ₹4,474 crore
- P/E
- 16.5
- P/B
- 2.01
- ROE
- 16.1%
- Dividend yield
- 1.20%
For the year ended Mar 2022, Epigral reported revenue of ₹1,551 crore and net profit of ₹253 crore, against ₹2,169 crore and ₹353 crore a year earlier.
Epigral annual profit and loss
Financial years, newest first. TTM = trailing twelve months.
| Item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|
| Revenue | 1,551 | 2,169 | 1,894 | 2,514 | 2,495 | 2,626 |
| Expenses | 1,041 | 1,480 | 1,413 | 1,804 | 1,927 | 2,043 |
| Operating profit | 509 | 689 | 481 | 711 | 568 | 583 |
| Operating margin % | 33% | 32% | 25% | 28% | 23% | 22% |
| Other income | 4 | -8 | -5 | 5 | -12 | 10 |
| Interest | 44 | 50 | 62 | 43 | 47 | 56 |
| Depreciation | 86 | 109 | 124 | 133 | 168 | 170 |
| Profit before tax | 383 | 522 | 291 | 541 | 341 | 367 |
| Tax % | 34% | 32% | 33% | 34% | 3% | 26% |
| Net profit | 253 | 353 | 196 | 358 | 332 | 271 |
| EPS (₹) | 60.84 | 85.03 | 47.14 | 82.91 | 76.95 | 62.82 |
| Dividend payout % | — | — | — | — | — | — |
Source: Company filings (consolidated), in ₹ crore. Data as of 7 October 2026. How this data is compiled.
Epigral financial results — frequently asked questions
What is Epigral's annual revenue and net profit?
For the financial year ended Mar 2022, Epigral's revenue was ₹1,551 crore and net profit ₹253 crore; net profit fell 28.33% from ₹353 crore in Mar 2023.
How fast has Epigral grown over three years?
From Mar 2025 to Mar 2022, Epigral's revenue grew at a compound annual rate of -14.9% and net profit at -10.9%. Past growth does not indicate future results.
What is the EPS of Epigral?
Annual EPS for Mar 2022 was ₹60.84.
Are these figures consolidated or standalone?
They are consolidated figures as reported by the company, in ₹ crore. Trailing-twelve-month and half-year columns are labelled separately and are not counted as financial years.
Same Data For Peers
Trade Epigral With ATS
Track EPIGRAL live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.